Press release
Artificial Intelligence (AI) In Clinical Trials Market Recent Development And Future Growth Forecast To 2033
Artificial Intelligence (AI) In Clinical Trials Market
The Business Research Company offers in-depth market insights through Artificial Intelligence AI In Clinical Trials Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The artificial intelligence (ai) in clinical trials market size has grown exponentially in recent years. It will grow from $1.52 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches.
The artificial intelligence (ai) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.6%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (nlp) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12603&type=smp
Market Segmentation:
The artificial intelligence (ai) in clinical trials market covered in this report is segmented -
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users
Major Driver - Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth
The growing need to curb clinical trial costs is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Clinical trials refer to research studies used to test medical, surgical, or behavioral intervention in people, and the costs of clinical trials include the cost of the research and the cost of patient care. Drug development and other clinical trial processes are costly by nature, and artificial intelligence is used to provide better drug discovery, better designed and safer clinical trials, and improved patient outcomes at lower costs. For instance, in February 2023, according to Genetic Engineering and Biotechnology News, a US-based platform that provides the latest information on genetic engineering and biotechnology, developing a new drug among the top 20 global biopharma companies rose by 15% from $298 million in 2022 to approximately $2.3 billion in 2023, and this includes the costs incurred from developing a drug through clinical trials. Furthermore, in January 2023, according to a report published by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, the adoption of AI within the next five years is expected to generate substantial cost savings in healthcare, ranging from 5 to 10% of healthcare spending, equating to approximately $200 billion to $360 billion in annual savings. Therefore, the growing need to curb clinical trial costs will drive artificial intelligence in the clinical trial market.
Competitive Landscape:
Major companies operating in the artificial intelligence (ai) in clinical trials market report are Medable Inc., PathAI inc., Saama Technologies Inc., Apellis Pharmaceuticals Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-clinical-trials-global-market-report
Top Trend - Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market
Innovative product offerings are a key trend in artificial intelligence in the clinical trial market. Major companies in the artificial intelligence in clinical trials market have introduced innovative product offerings to sustain their position in the market. For instance, in January 2023, Elligo Health Research Inc., a US-based healthcare-enabling research organization, launched DataAI Connect, an innovative data and technology platform that enables rapid, data-driven clinical research. The platform effortlessly gathers, manages, evaluates, and shares real-world patient data, presenting a comprehensive strategy to overcome clinical trial obstacles instead of acting as an accessory technology. This adaptable and sustainable platform includes an all-in-one solution for retrieving and evaluating medical records. It adeptly transforms data into practical insights and individual patient progress information, leveraging cutting-edge technologies such as NLP, ML, and clinical acumen.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Artificial Intelligence AI In Clinical Trials Market Characteristics
3. Artificial Intelligence AI In Clinical Trials Market Trends And Strategies
4. Artificial Intelligence AI In Clinical Trials Market - Macro Economic Scenario
5. Artificial Intelligence AI In Clinical Trials Market Size And Growth
…..
27. Artificial Intelligence AI In Clinical Trials Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) In Clinical Trials Market Recent Development And Future Growth Forecast To 2033 here
News-ID: 3434389 • Views: …
More Releases from The Business research company
Leading Companies Fueling Growth and Innovation in the Sun Care Products Market
The sun care products market is on track for substantial expansion as consumer awareness about skin protection intensifies worldwide. With evolving preferences and technological advancements shaping product offerings, this sector is set to witness robust growth in the coming years. Let's explore the market's size projections, key players, emerging trends, and major segments driving its development through 2030.
Projected Size and Growth Trajectory of the Sun Care Products Market
The…
Future Perspectives: Key Trends Shaping the Styrene Butadiene Rubber (SBR) Based …
The styrene butadiene rubber (SBR) based adhesive market is on track for notable growth as we approach 2030. Driven by a variety of factors including expanding infrastructure projects and rising demand across multiple industries, this sector is poised for steady expansion. Let's explore the market's size projections, key players, emerging trends, and the main segments shaping its future.
Projected Growth and Market Size of Styrene Butadiene Rubber Based Adhesives
The…
Emerging Sub-Segments Transforming the Stearic Acid Market Landscape
The stearic acid market is poised for significant expansion in the coming years, driven by evolving demand across various industries. This report explores the projected market size, leading companies, key trends, and segment analysis shaping the future of this vital chemical.
Stearic Acid Market Size and Growth Outlook
The stearic acid market is set to grow robustly, reaching a valuation of $54.63 billion by 2030. This represents a compound annual…
Market Trend Insights: The Impact of Recent Innovations on the Specialty Pestici …
The specialty pesticides sector is on the verge of significant expansion as global agricultural practices continue to evolve. Driven by increasing demand for crop protection and sustainable farming techniques, this market is set to experience robust growth in the coming years. Let's explore the market's anticipated value, leading companies, emerging trends, and detailed segmentation to gain a comprehensive understanding of this dynamic industry.
Projected Market Size and Growth Expectations for Specialty…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
